These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3535805)

  • 1. Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.
    Park KS; el Kouni MH; Krenitsky TA; Chu SH; Cha S
    Biochem Pharmacol; 1986 Nov; 35(21):3853-5. PubMed ID: 3535805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
    Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
    Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
    Naguib FN; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of inhibitors of pyrimidine metabolism.
    Cha SM
    Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.
    Drabikowska AK; Lissowska L; Veres Z; Shugar D
    Biochem Pharmacol; 1987 Dec; 36(23):4125-8. PubMed ID: 3318842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase.
    Drabikowska AK; Lissowska L; Draminski M; Zgit-Wroblewska A; Shugar D
    Z Naturforsch C J Biosci; 1987 Mar; 42(3):288-96. PubMed ID: 2954322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
    Lee KH; el Kouni MH; Chu HS; Cha S
    Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
    Iltzsch MH; Klenk EE
    Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 1-[[2-hydroxy-1-(hydroxymethyl)ethoxy] methyl]-5-benzyluracil and its amino analogue, new potent uridine phosphorylase inhibitors with high water solubility.
    Lin TS; Liu MC
    J Med Chem; 1985 Jul; 28(7):971-3. PubMed ID: 4009620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Substituted-2,2'-anhydrouridines, potent inhibitors of uridine phosphorylase.
    Veres Z; Szabolcs A; Szinai I; Dénes G; Kajtár-Peredy M; Otvös L
    Biochem Pharmacol; 1985 May; 34(10):1737-40. PubMed ID: 4004890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of two novel inhibitors of uridine phosphorylase.
    Siegel SA; Lin TS
    Biochem Pharmacol; 1985 Apr; 34(7):1121-4. PubMed ID: 3985996
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiation of 5-fluoro-2'-deoxyuridine antineoplastic activity by the uridine phosphorylase inhibitors benzylacyclouridine and benzyloxybenzylacyclouridine.
    Chu MY; Naguib FN; Iltzsch MH; el Kouni MH; Chu SH; Cha S; Calabresi P
    Cancer Res; 1984 May; 44(5):1852-6. PubMed ID: 6231986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
    Niedzwicki JG; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of uridine phosphorylase from Giardia lamblia by pyrimidine analogs.
    Jiménez BM; Kranz P; Lee CS; Gero AM; O'Sullivan WJ
    Biochem Pharmacol; 1989 Nov; 38(21):3785-9. PubMed ID: 2597172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.
    Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase.
    Naguib FN; Levesque DL; Wang EC; Panzica RP; el Kouni MH
    Biochem Pharmacol; 1993 Oct; 46(7):1273-83. PubMed ID: 8216379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil.
    Kelley JL; Baker BR
    J Med Chem; 1982 May; 25(5):600-3. PubMed ID: 6211547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uridine phosphorylase from Schistosoma mansoni.
    el Kouni MH; Naguib FN; Niedzwicki JG; Iltzsch MH; Cha S
    J Biol Chem; 1988 May; 263(13):6081-6. PubMed ID: 3360774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.
    Bu W; Settembre EC; el Kouni MH; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):863-72. PubMed ID: 15983408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver.
    Monks A; Ayers O; Cysyk RL
    Biochem Pharmacol; 1983 Jul; 32(13):2003-9. PubMed ID: 6870929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.